Sub-prime installment lender trading at ~6.3x forward P/E and ~1.05x tangible book despite +14% YTD net income, EPS growth guidance of 10-13% and improving operating efficiency. Bank-partnership expansion (targeted 200 bps pre-tax margin uplift) is a structural earnings catalyst not yet priced in. Main risks are cyclical credit losses (NCL rate 12.2%) and reliance on securitization funding. Consensus target $43-45 implies ~30-35% upside; base FV supports similar range.
P/E on forward diluted EPS derived from company guidance (Q2 2026 call: FY26 EPS growth +10-13%). Peer-anchored multiple derivation: median 10x, 25% quality discount → 7.5x on core, 8x on incremental growth. Bank-partnership option: probability-weighted NPV of 200 bps pre-tax margin uplift on partial portfolio share. Reserve cushion isolated separately (excess coverage above peer avg). Implied multiple of FV (8.3x) sits inside ±20% band vs nominal 7.5x. Cross-check with P/Tangible Book (est. ~$31/sh) at 1.35x peer median × quality haircut lands within ±2% of the P/E-based FV. Sensitivity: ±1x on core P/E → ±$5.2/sh. ⚠️ Not investment advice.
| Component | Assumption | USD/share |
|---|---|---|
| Core lending earnings (FY26E) | FY26E diluted EPS $5.21 × 7.5x P/E (peer median 10x − 25% quality discount) | +39.10 |
| FY27 portfolio-growth uplift | Incremental EPS +7% → $0.36 × 8x forward P/E, PV-discounted 1yr @ 10% | +2.60 |
| Bank-partnership option | 40% prob × 200 bps pre-tax margin × ~$1.5B like-for-like receivables × (1−22% tax) / 9.22M sh | +1.00 |
| Excess reserve cushion vs peers | Allowance 10.4% of receivables vs peer avg ~8.5% → ~$40M excess buffer / 9.22M sh × 15% capture | +0.65 |
| Buyback / dilution | Shares stable ~9.2M (no shelf, no material buyback in place) → net neutral | −0.25 |
| FV base case | Sum: 39.10 + 2.60 + 1.00 + 0.65 − 0.25 = 43.10 | ≈ $43.10 |
Short interest ~7.5% is moderate and typical of small-cap sub-prime lenders in a mid-credit-cycle window. No signs of concentrated bear thesis (no active short-seller report identified in last 12 months). Insider Form 4 activity: CEO Robert Beck sold ~13k shs in Feb 2025 and shareholder Forager Fund purchased 11k shs Jun 2025 — no material insider selling above $500k threshold in the last 12 months.
| Item | FY23A | FY24A | FY25A | FY26E | Guidance FY26 |
|---|---|---|---|---|---|
| Revenue ($M) | 541 | 571 | 646 | ~690 | Portfolio +5-7% |
| Net income ($M) | 21 | 41 | 44.4 | ~47-48 | +6-9% YoY |
| Diluted EPS ($) | 2.15 | 4.28 | 4.71 | ~5.20 | +10-13% |
| Net finance recv. ($B) | 1.74 | 1.87 | 2.02 | ~2.16 | +5-7% |
| NCL rate (%) | 11.8 | 12.4 | 12.0 | ~12.0 | Stable |
| OpEx ratio (%) | 14.0 | 13.2 | 12.6 | ~12.3 | Further -30 bps |
| ROE (%) | 7.5 | 13.6 | 14.5 | ~14.5-15 | Stable |
| Metric | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| Revenue ($M) | 157 | 165 | 163 | 162 | 168 |
| NII yield (%) | 33.0 | 33.4 | 33.6 | 33.5 | 33.4 |
| Net income ($M) | 7.2 | 13.1 | 12.6 | 8.6 | 8.2 |
| Diluted EPS ($) | 0.72 | 1.33 | 1.28 | 0.90 | 0.85 |
| NCL rate (%) | 12.1 | 11.8 | 11.9 | 12.4 | 12.2 |
| Delinquency 30+ (%) | 6.8 | 6.9 | 7.0 | 7.1 | 7.0 |
Business model — Non-prime installment lending, five-state footprint expanding
Revenue mix (est. FY26): Large installment loans ~65% / Small installment loans ~20% / Auto-secured ~11% / Insurance & other fees ~4%. Portfolio growth is being driven by the two collateralized/higher-quality segments (+17% and +32% YoY respectively in Q2 2026), while small unsecured has been deliberately shrunk.
Legal, regulatory and risk analysis
SWOT analysis
- +Consistent profitability: ROE ~14% and improving OpEx ratio (12.4%, -80 bps YoY)
- +Stable dividend ($1.20/yr, ~3.6% yield) with modest payout ratio (~24%)
- +Reserve coverage 10.4% of receivables — cushion above peer avg
- +Portfolio de-risking: 78%+ now large loans or auto-secured (collateralized)
- +Insider ownership >20% aligns management with shareholders
- −NCL rate 12.2% structurally higher than large-cap peers (OMF ~9%)
- −Geographic concentration in 5 southern US states
- −Reliance on ABS/warehouse funding — exposed to spread widening
- −Micro-cap liquidity limits institutional accumulation
- −Q2 revenue miss vs consensus (managing volume for return, not growth)
- →Bank-partnership rollout: +200 bps pre-tax margin uplift by end-2027
- →Fed rate cuts would compress funding costs, expanding NIM
- →Multiple re-rating toward peer median (~10x fw P/E) worth >$14/sh
- →Geographic expansion possible once bank-partner model is proven
- →Consolidation opportunity: sub-scale peers could be acquired
- !US recession → NCL spike, reserve build, EPS compression
- !CFPB / state-level rate-cap regulation on non-prime lending
- !Legal challenges to rent-a-charter bank-partnership model
- !Wage-growth stall combined with sticky inflation squeezes borrower ability-to-pay
- !Peer aggressive pricing eroding NIM in higher-quality segments
Summary by assessment area
- Fw P/E ~6.3x vs peer median ~10x → ~35% discount
- P/tangible book ~1.05x, within historical range
- Consensus target $43-45 implies 30-35% upside
- NCL 12.2% already elevated vs mid-cycle ~10%
- Reserve cushion 10.4% absorbs mild deterioration
- Recession scenario is the main bear-case trigger
- Bank partnership expansion is a real earnings lever
- Portfolio quality mix improving each quarter
- Stable, seasoned management with skin in the game
Sources: RM Q2 2026 earnings release & 10-Q (Aug 2026), Q2 2026 earnings call transcript (The Motley Fool, 2026-08-07), MarketBeat historical prices (last update 2026-09-03), Simply Wall St analysis, Investing.com consensus estimates, StockAnalysis.com, GuruFocus, macrotrends peer PE data. Market data — last verified close 2026-09-03: RM $33.05, market cap $304.92M, 52W $25.41–$37.52, shares outstanding ~9.22M. Short interest ~7.5% (est). Prezzo usato: $33.05 (close 2026-09-03, T-1) — fonti: MarketBeat, Simply Wall St. This document is for informational purposes only and does not constitute financial or investment advice.